Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""DIABETES"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1017778
Tytuł:
Prevalence of diabetes, epidemiological characteristics and vascular complications.
Autorzy:
Russo MP; Servicio de Clínica Médica.
Grande-Ratti MF; Servicio de Clínica Médica.; Área de Investigación en Medicina Interna.; Consejo Nacional de Investigaciones Científicas y Técnicas, Departamento de Medicina. Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Burgos MA; Área de Investigación en Medicina Interna.
Molaro AA; Servicio de Clínica Médica.
Bonella MB; Servicio de Clínica Médica.
Pokaż więcej
Transliterated Title:
Prevalencia de diabetes, características epidemiológicas y complicaciones vasculares.
Źródło:
Archivos de cardiologia de Mexico [Arch Cardiol Mex] 2023; Vol. 93 (1), pp. 30-36.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Ambulatory Care*/statistics & numerical data
Diabetes Mellitus*/epidemiology
Diabetic Angiopathies*/epidemiology
Diabetic Angiopathies*/therapy
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Argentina/epidemiology ; Comorbidity ; Cross-Sectional Studies ; Diabetes Complications/epidemiology ; Diabetes Mellitus, Type 2/epidemiology ; Glycated Hemoglobin/analysis ; Heart Disease Risk Factors ; Hypertension/epidemiology ; Insurance, Health/statistics & numerical data ; Prevalence ; Risk Factors
Czasopismo naukowe
Szczegóły
Tytuł:
Paeoniflorin protects NOD mice from T1D through regulating gut microbiota and TLR4 mediated myD88/TRIF pathway.
Autorzy:
Luo C; Department of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, PR China.
Yang D; Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, PR China; Hunan Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan Province, PR China.
Hou C; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, PR China.
Tan T; Department of Immunology, School of Basic Medical Sciences, Central South University, Changsha 410008, Hunan Province, PR China.
Chao C; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, PR China. Electronic address: .
Pokaż więcej
Źródło:
Experimental cell research [Exp Cell Res] 2023 Jan 01; Vol. 422 (1), pp. 113429. Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gastrointestinal Microbiome*/drug effects
Diabetes Mellitus, Experimental*/drug therapy
Diabetes Mellitus, Experimental*/microbiology
Animals ; Mice ; Adaptor Proteins, Vesicular Transport/genetics ; Diabetes Mellitus, Type 1/drug therapy ; Diabetes Mellitus, Type 1/microbiology ; Mice, Inbred C57BL ; Mice, Inbred NOD ; Myeloid Differentiation Factor 88/metabolism ; Signal Transduction ; Toll-Like Receptor 4/drug effects ; Toll-Like Receptor 4/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
The efficacy of PDE5 inhibitors in diabetic patients.
Autorzy:
Swiecicka A; Department of Basic and Clinical Sciences, University of Nicosia Medical School, Nicosia, Cyprus.
Pokaż więcej
Źródło:
Andrology [Andrology] 2023 Feb; Vol. 11 (2), pp. 245-256. Date of Electronic Publication: 2022 Dec 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetes Mellitus*/drug therapy
Phosphodiesterase 5 Inhibitors*/therapeutic use
Animals ; Humans ; Male ; Cardiovascular Diseases/drug therapy ; Diabetes Complications ; Metabolic Syndrome/drug therapy
Czasopismo naukowe
Szczegóły
Tytuł:
Sympathetic System in Wound Healing: Multistage Control in Normal and Diabetic Skin.
Autorzy:
Ivanov E; Faculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
Akhmetshina M; Faculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
Erdiakov A; Faculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
Gavrilova S; Faculty of Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jan 20; Vol. 24 (3). Date of Electronic Publication: 2023 Jan 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetes Complications*/metabolism
Wound Healing*/physiology
Sympathetic Nervous System*/metabolism
Skin*/blood supply
Skin*/metabolism
Skin Ulcer*/metabolism
Skin Ulcer*/physiopathology
Humans ; Diabetes Mellitus/metabolism ; Hemodynamics ; Inflammation/metabolism ; Receptors, Adrenergic/metabolism ; Neurons/metabolism ; Vasoconstriction/physiology ; Neuropeptide Y/metabolism ; Norepinephrine/metabolism ; Acetylcholine/metabolism ; Vasoactive Intestinal Peptide/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hedgehog interacting protein activates sodium-glucose cotransporter 2 expression and promotes renal tubular epithelial cell senescence in a mouse model of type 1 diabetes.
Autorzy:
Zhao XP; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Department of Medicine, Université de Montréal, Montréal, QC, Canada.
Chang SY; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Department of Medicine, Université de Montréal, Montréal, QC, Canada.
Pang Y; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Department of Medicine, Université de Montréal, Montréal, QC, Canada.
Liao MC; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Department of Medicine, Université de Montréal, Montréal, QC, Canada.
Peng J; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Department of Medicine, Université de Montréal, Montréal, QC, Canada.
Ingelfinger JR; Harvard Medical School, Pediatric Nephrology Unit, Massachusetts General Hospital, Boston, MA, USA.
Chan JSD; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Department of Medicine, Université de Montréal, Montréal, QC, Canada.
Zhang SL; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Department of Medicine, Université de Montréal, Montréal, QC, Canada. .
Pokaż więcej
Źródło:
Diabetologia [Diabetologia] 2023 Jan; Vol. 66 (1), pp. 223-240. Date of Electronic Publication: 2022 Oct 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*/genetics
Sodium-Glucose Transporter 2*/genetics
Carrier Proteins*/genetics
Membrane Glycoproteins*/genetics
Animals ; Humans ; Mice ; Epithelial Cells ; Hedgehog Proteins ; Mice, Transgenic ; Diabetes Mellitus, Experimental/genetics ; Kidney Tubules/cytology ; Cellular Senescence
Czasopismo naukowe
Szczegóły
Tytuł:
Magnolol effectively ameliorates diabetic peripheral neuropathy in mice.
Autorzy:
Yang J; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia, Nanjing 210023, China.
Wei Y; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia, Nanjing 210023, China.
Zhao T; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia, Nanjing 210023, China.
Li X; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia, Nanjing 210023, China.
Zhao X; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia, Nanjing 210023, China.
Ouyang X; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia, Nanjing 210023, China.
Zhou L; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia, Nanjing 210023, China.
Zhan X; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia, Nanjing 210023, China.
Qian M; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia, Nanjing 210023, China. Electronic address: .
Wang J; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia, Nanjing 210023, China. Electronic address: .
Shen X; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia, Nanjing 210023, China. Electronic address: .
Pokaż więcej
Źródło:
Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2022 Dec; Vol. 107, pp. 154434. Date of Electronic Publication: 2022 Sep 05.
Typ publikacji:
Journal Article
MeSH Terms:
Biphenyl Compounds*/pharmacology
Diabetes Mellitus, Experimental*/complications
Diabetes Mellitus, Experimental*/drug therapy
Diabetes Mellitus, Experimental*/metabolism
Diabetic Neuropathies*/drug therapy
Lignans*/pharmacology
Animals ; Male ; Mice ; AMP-Activated Protein Kinases/metabolism ; Biological Products/pharmacology ; Diabetes Mellitus, Type 1/complications ; Diabetes Mellitus, Type 1/drug therapy ; Diabetes Mellitus, Type 1/metabolism ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/metabolism ; Hypoglycemic Agents/pharmacology ; NF-kappa B/metabolism ; PPAR gamma/metabolism ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Sciatic Nerve ; Sirtuin 1/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Relationship between the Responsiveness of Amyloid β Protein to Platelet Activation by TRAP Stimulation and Brain Atrophy in Patients with Diabetes Mellitus.
Autorzy:
Hori T; Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.; Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.; Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Mizutani D; Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.; Department of Neurosurgery, Toki Municipal General Hospital, Toki 509-5193, Japan.
Onuma T; Department of Anesthesiology and Pain Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Okada Y; Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Kojima K; Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Doi T; Department of Emergency and Disaster Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Enomoto Y; Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Iida H; Department of Anesthesiology and Pain Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Ogura S; Department of Emergency and Disaster Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Sakurai T; Center for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.; Department of Cognitive and Behavioral Science, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Iwama T; Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Kozawa O; Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.; Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Tokuda H; Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.; Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.; Department of Clinical Laboratory/Medical Genome Center, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Nov 15; Vol. 23 (22). Date of Electronic Publication: 2022 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
Amyloid beta-Peptides*/metabolism
Platelet Activation*/physiology
Diabetes Complications*/metabolism
Diabetes Complications*/pathology
Humans ; Alzheimer Disease ; Atrophy/metabolism ; Brain/metabolism ; Brain/pathology ; Diabetes Mellitus/metabolism ; Diabetes Mellitus/pathology ; HSP27 Heat-Shock Proteins/metabolism ; Receptor, PAR-1/metabolism ; Receptors, Thrombin/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Fibroblast-specific activation of Rnd3 protects against cardiac remodeling in diabetic cardiomyopathy via suppression of Notch and TGF-β signaling.
Autorzy:
Zhang Y; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Cao Y; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Zheng R; Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, China.
Xiong Z; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Zhu Z; Department of Otolaryngology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Gao F; Department of General Practice, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Man W; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Duan Y; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Lin J; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Zhang X; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Wu D; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Jiang M; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Zhang X; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Li C; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Gu X; Department of Physiology and Pathophysiology, Fourth Military Medical University, Xi'an, China.
Fan Y; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Sun D; Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Pokaż więcej
Źródło:
Theranostics [Theranostics] 2022 Oct 17; Vol. 12 (17), pp. 7250-7266. Date of Electronic Publication: 2022 Oct 17 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2*/genetics
Diabetes Mellitus, Type 2*/metabolism
Diabetes Mellitus, Type 2*/pathology
Diabetic Cardiomyopathies*/genetics
Diabetic Cardiomyopathies*/metabolism
Diabetic Cardiomyopathies*/pathology
Ventricular Remodeling*/genetics
Ventricular Remodeling*/physiology
Myofibroblasts*/metabolism
Myofibroblasts*/pathology
Animals ; Mice ; Diabetes Mellitus, Experimental/genetics ; Diabetes Mellitus, Experimental/metabolism ; Diabetes Mellitus, Experimental/pathology ; Fibroblasts/metabolism ; Fibroblasts/pathology ; Mice, Transgenic ; rho GTP-Binding Proteins/genetics ; rho GTP-Binding Proteins/metabolism ; Transforming Growth Factor beta/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Clinical features, biochemistry, and HLA-DRB1 status in youth-onset type 1 diabetes in Mali.
Autorzy:
Besançon S; ONG Santé Diabète, Bamako, Mali.
Govender D; Life for a Child Program, Diabetes NSW & ACT, Glebe, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Sidibé AT; Endocrinology and Diabetes, Hopital du Mali, Bamako, Mali.
Noble JA; Children's Hospital Oakland Research Institute, Oakland, California, USA.; Department of Pediatrics, University of California, San Francisco, Oakland, California, USA.
Togo A; Endocrinology and Diabetes, Hopital du Mali, Bamako, Mali.
Lane JA; Children's Hospital Oakland Research Institute, Oakland, California, USA.
Mack SJ; Department of Pediatrics, University of California, San Francisco, Oakland, California, USA.
Atkinson MA; Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, Diabetes Institute, University of Florida, Gainesville, Florida, USA.; Department of Pediatrics, College of Medicine, Diabetes Institute, Oakland, California, USA.
Wasserfall CH; Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, Diabetes Institute, University of Florida, Gainesville, Florida, USA.
Kakkat F; Life for a Child Program, Diabetes NSW & ACT, Glebe, New South Wales, Australia.
Martin GGN; Children's Hospital Oakland Research Institute, Oakland, California, USA.
Ogle GD; Life for a Child Program, Diabetes NSW & ACT, Glebe, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło:
Pediatric diabetes [Pediatr Diabetes] 2022 Dec; Vol. 23 (8), pp. 1552-1559. Date of Electronic Publication: 2022 Sep 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*/genetics
HLA-DRB1 Chains*/genetics
Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Young Adult ; Autoantibodies/blood ; Autoantibodies/chemistry ; C-Peptide/blood ; C-Peptide/chemistry ; Diabetes Mellitus, Type 2/genetics ; Genetic Predisposition to Disease ; Glutamate Decarboxylase ; Mali/epidemiology
Czasopismo naukowe
Szczegóły
Tytuł:
Is Alzheimer's disease a type 3 diabetes? A review.
Autorzy:
Janoutová J; Faculty of Medicine, Palacky University in Olomouc, Olomouc, Czech Republic.
Machaczka O; Faculty of Health Sciences, Palacky University in Olomouc, Olomouc, Czech Republic.
Zatloukalová A; Faculty of Health Sciences, Palacky University in Olomouc, Olomouc, Czech Republic.
Janout V; Faculty of Health Sciences, Palacky University in Olomouc, Olomouc, Czech Republic.
Pokaż więcej
Źródło:
Central European journal of public health [Cent Eur J Public Health] 2022 Sep; Vol. 30 (3), pp. 139-143.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Alzheimer Disease*/complications
Alzheimer Disease*/epidemiology
Cognitive Dysfunction*/complications
Cognitive Dysfunction*/epidemiology
Diabetes Mellitus*
Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/epidemiology ; Humans ; Hypoglycemic Agents/therapeutic use ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Quercetin ameliorates oxidative stress‑induced cell apoptosis of seminal vesicles via activating Nrf2 in type 1 diabetic rats.
Autorzy:
Dong B; Medical College of Soochow University, Suzhou, China; Department of Urology, Xuzhou Central Hospital, Xuzhou, China; Department of Urology, Suining People's Hospital, Xuzhou, China.
Shi Z; Department of Urology, Xuzhou Central Hospital, Xuzhou, China.
Dong Y; Medical College of Soochow University, Suzhou, China; Department of Urology, Xuzhou Central Hospital, Xuzhou, China.
Chen J; Medical College of Soochow University, Suzhou, China.
Wu ZX; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York, USA.
Wu W; Medical College of Soochow University, Suzhou, China.
Chen ZS; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York, USA. Electronic address: .
Han C; Medical College of Soochow University, Suzhou, China; Department of Urology, Xuzhou Central Hospital, Xuzhou, China. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Jul; Vol. 151, pp. 113108. Date of Electronic Publication: 2022 May 17.
Typ publikacji:
Journal Article
MeSH Terms:
Apoptosis*
Diabetes Mellitus, Experimental*/drug therapy
Diabetes Mellitus, Experimental*/metabolism
NF-E2-Related Factor 2*/metabolism
Quercetin*/pharmacology
Quercetin*/therapeutic use
Seminal Vesicles*/drug effects
Seminal Vesicles*/metabolism
Animals ; Male ; Rats ; Antioxidants/metabolism ; bcl-2-Associated X Protein/metabolism ; Blood Glucose/metabolism ; Diabetes Mellitus, Type 1/drug therapy ; Diabetes Mellitus, Type 1/metabolism ; Oxidative Stress/drug effects ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Rats, Sprague-Dawley
Czasopismo naukowe
Szczegóły
Tytuł:
The mitochondria-targeted antioxidant MitoQ ameliorates myocardial ischemia-reperfusion injury by enhancing PINK1/Parkin-mediated mitophagy in type 2 diabetic rats.
Autorzy:
Ji Y; Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China.
Leng Y; Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China.
Lei S; Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China.
Qiu Z; Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China.
Ming H; Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China.
Zhang Y; Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China.
Zhang A; Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China.
Wu Y; Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China. .
Xia Z; Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China. .
Pokaż więcej
Źródło:
Cell stress & chaperones [Cell Stress Chaperones] 2022 Jul; Vol. 27 (4), pp. 353-367. Date of Electronic Publication: 2022 Apr 15.
Typ publikacji:
Journal Article
MeSH Terms:
Antioxidants*/pharmacology
Diabetes Mellitus, Experimental*/drug therapy
Diabetes Mellitus, Experimental*/metabolism
Myocardial Reperfusion Injury*/drug therapy
Myocardial Reperfusion Injury*/metabolism
Protein Kinases*/metabolism
Ubiquitin-Protein Ligases*/metabolism
Animals ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/metabolism ; Mitochondria/metabolism ; Mitophagy ; Organophosphorus Compounds ; Rats ; Rats, Sprague-Dawley ; Ubiquinone/analogs & derivatives
Czasopismo naukowe
Szczegóły
Tytuł:
The efficacy of a paeoniflorin-sodium alginate-gelatin skin scaffold for the treatment of diabetic wound: An in vivo study in a rat model.
Autorzy:
Yu H; Department of Interventional and Vascular Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, China.
Gong W; Department of Pathology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, China.
Mei J; Department of Interventional and Vascular Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, China.
Qin L; Department of Interventional and Vascular Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, China.
Piao Z; Department of Interventional and Vascular Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, China.
You D; Department of Radiology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, China.
Gu W; Department of Pathology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, China. Electronic address: .
Jia Z; Department of Interventional and Vascular Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, China. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Jul; Vol. 151, pp. 113165. Date of Electronic Publication: 2022 May 24.
Typ publikacji:
Journal Article
MeSH Terms:
Alginates*/administration & dosage
Alginates*/therapeutic use
Diabetes Complications*/complications
Diabetes Complications*/therapy
Gelatin*/administration & dosage
Gelatin*/therapeutic use
Glucosides*/administration & dosage
Glucosides*/therapeutic use
Skin*/blood supply
Skin*/drug effects
Skin*/injuries
Tissue Scaffolds*
Animals ; Collagen/metabolism ; Diabetes Mellitus ; Disease Models, Animal ; Microvessels/drug effects ; Microvessels/physiology ; Monoterpenes/administration & dosage ; Monoterpenes/therapeutic use ; Printing, Three-Dimensional ; Rats ; Wound Healing/drug effects ; Wound Healing/physiology ; Wounds and Injuries/complications ; Wounds and Injuries/physiopathology ; Wounds and Injuries/therapy
Czasopismo naukowe
Szczegóły
Tytuł:
Effects of Elobixibat in Patients with Diabetes and Concomitant Chronic Constipation: an 8-week, Prospective, Single-center, Single-arm Study.
Autorzy:
Hishida Y; Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Nagai Y; Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan. .; Department of Diabetes and Endocrinology, Kanto Rosai Hospital, 1-1, Kizukisumiyoshi, Nakahara, Kawasaki, Kanagawa, 211-8510, Japan. .
Tsukiyama H; Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Nakamura Y; Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Nakagawa T; Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Ishizaki S; Medical Department, EA Pharma Co., Ltd., 2-1-1, Irifune, Chuo-Ku, Tokyo, 104-0042, Japan.
Tanaka Y; Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.; Diabetes Center, Yokohama General Hospital, 2201-5, Kuroganechou, Aoba-ku, Yokohama, Kanagawa, 225-0025, Japan.
Sone M; Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Pokaż więcej
Źródło:
Advances in therapy [Adv Ther] 2022 Sep; Vol. 39 (9), pp. 4205-4217. Date of Electronic Publication: 2022 Jul 22.
Typ publikacji:
Clinical Study; Journal Article
MeSH Terms:
Constipation*/complications
Constipation*/drug therapy
Diabetes Mellitus*/drug therapy
Dipeptides*/adverse effects
Thiazepines*/adverse effects
Aged ; Diabetes Complications ; Female ; Humans ; Lipids ; Male ; Prospective Studies ; Quality of Life ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
Novel topical esmolol hydrochloride improves wound healing in diabetes by inhibiting aldose reductase, generation of advanced glycation end products, and facilitating the migration of fibroblasts.
Autorzy:
Kulkarni SA; Department of Molecular Diabetes, NovaLead Pharma Pvt. Ltd., Pune, India.
Deshpande SK; Department of Molecular Diabetes, NovaLead Pharma Pvt. Ltd., Pune, India.
Rastogi A; Department of Endocrinology, Post Graduate Institute of Medical Education and research (PGIMER), Chandigarh, India.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Aug 23; Vol. 13, pp. 926129. Date of Electronic Publication: 2022 Aug 23 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus*/drug therapy
Glycation End Products, Advanced*/drug effects
Glycation End Products, Advanced*/metabolism
Wound Healing*/drug effects
Aldehyde Reductase/antagonists & inhibitors ; Animals ; Diabetes Complications/drug therapy ; Endothelial Cells ; Fibroblasts/drug effects ; Fibroblasts/metabolism ; Glucose/pharmacology ; Humans ; Hydroxyproline/pharmacology ; Nitric Oxide/pharmacology ; Propanolamines ; Rats ; Sorbitol/pharmacology ; Streptozocin ; Swine ; Swine, Miniature
Czasopismo naukowe
Szczegóły
Tytuł:
Blood hemoglobin A1c might predict adverse differences in heart rate variability in a diabetic population: Evidence from the Midlife in the United States (MIDUS) study.
Autorzy:
Huang Y; Rehabilitation Department, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Chen H; Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Hu D; Rehabilitation Department, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Wan R; Jiangxi Key Laboratory of Molecular Medicine, Nanchang, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Aug 23; Vol. 13, pp. 921287. Date of Electronic Publication: 2022 Aug 23 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Autonomic Nervous System*/pathology
Diabetes Mellitus*/metabolism
Glycated Hemoglobin*/chemistry
Glycated Hemoglobin*/metabolism
Heart Rate*/physiology
Adult ; Cross-Sectional Studies ; Diabetes Complications/diagnosis ; Humans
Czasopismo naukowe
Szczegóły
Tytuł:
Distribution and characteristics of newly-defined subgroups of type 2 diabetes in randomised clinical trials: Post hoc cluster assignment analysis of over 12,000 study participants.
Autorzy:
Landgraf W; Sanofi, Frankfurt, Germany. Electronic address: .
Bigot G; IVIDATA Life Sciences, Levallois-Perret, France.
Hess S; Sanofi, Frankfurt, Germany.
Asplund O; Lund University Diabetes Centre, Department of Clinical Sciences, Skåne University Hospital, Malmö, Sweden.
Groop L; Institute of Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Ahlqvist E; Lund University Diabetes Centre, Department of Clinical Sciences, Skåne University Hospital, Malmö, Sweden.
Käräjämäki A; Department of Primary Health Care, Vaasa Central Hospital, and Diabetes Center, Vaasa Health Care Center, Vaasa, Finland.
Owens DR; Swansea University, Diabetes Research Group Cymru, College of Medicine, Swansea, UK.
Frier BM; The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Bolli GB; University of Perugia School of Medicine, Department of Medicine, Section of Endocrinology and Metabolism, Perugia, Italy.
Pokaż więcej
Źródło:
Diabetes research and clinical practice [Diabetes Res Clin Pract] 2022 Aug; Vol. 190, pp. 110012. Date of Electronic Publication: 2022 Jul 18.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Complications/complications ; Fasting ; Glycated Hemoglobin ; Humans ; Hyperglycemia/complications ; Insulin/therapeutic use ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Szczegóły
Tytuł:
Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway.
Autorzy:
Ren M; Department of Cardiology, Yijishan Hospital, Wannan Medical College, Anhui Province, China 241001.
Pan D; Department of Cardiology, Yijishan Hospital, Wannan Medical College, Anhui Province, China 241001.
Zha D; Department of Cardiology, Wuhu Second People's Hospital, Anhui Province, China 241001.
Shan Z; Department of Cardiology, Bengbu Second People's Hospital, Anhui Province, China 233000.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2022 Jul 26; Vol. 2022, pp. 9687345. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Benzhydryl Compounds*/pharmacology
Diabetes Mellitus, Experimental*/drug therapy
Diabetes Mellitus, Experimental*/metabolism
Diabetic Cardiomyopathies*/drug therapy
Diabetic Cardiomyopathies*/metabolism
Glucosides*/pharmacology
Animals ; Connexin 43 ; Diabetes Mellitus, Type 2 ; Heart Failure/prevention & control ; Proto-Oncogene Proteins c-akt/metabolism ; Rats ; Signal Transduction ; TOR Serine-Threonine Kinases/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
Autorzy:
Ali SK; Department of Pharmacology and Toxicology, Hawler Medical University, Erbil, Iraq.
Ali RH; Department of Pharmacology and Toxicology, Hawler Medical University, Erbil, Iraq.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jul 08; Vol. 17 (7), pp. e0271138. Date of Electronic Publication: 2022 Jul 08 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/metabolism
Diabetes Mellitus, Type 2*/drug therapy
Hypoglycemic Agents*/pharmacology
Hypoglycemic Agents*/therapeutic use
Metformin*/pharmacology
Metformin*/therapeutic use
Acetylcholinesterase/metabolism ; Amyloid Precursor Protein Secretases/metabolism ; Amyloid beta-Peptides/metabolism ; Animals ; Biomarkers ; Cholesterol ; Diabetes Mellitus, Experimental/chemically induced ; Diabetes Mellitus, Experimental/drug therapy ; Donepezil ; Glucose/metabolism ; Glyburide/therapeutic use ; Glycated Hemoglobin ; Insulin Glargine/therapeutic use ; Male ; Malondialdehyde ; Microtubule-Associated Proteins ; Nitric Oxide/therapeutic use ; Rats ; Rats, Wistar ; Streptozocin ; Triglycerides ; Tumor Necrosis Factor-alpha/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Precision therapy for three Chinese families with maturity-onset diabetes of the young (MODY12).
Autorzy:
Li J; Department of Pharmacy, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang X; Department of Pain, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Mao H; Department of Nephrology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wen L; Department of Traditional Chinese Medicine and Ethnic Medicine, Guangxi Institute for Food and Drug Control, Nanning, China.
Deng A; Department of Pharmacy, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li Y; Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang H; Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu C; Hubei Key Laboratory of Diabetes and Angiopathy, Hubei University of Science and Technology, Xianning, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Aug 03; Vol. 13, pp. 858096. Date of Electronic Publication: 2022 Aug 03 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Blood Glucose*
Diabetes Mellitus*
Adult ; Child ; China/epidemiology ; DNA Mutational Analysis ; Diabetes Mellitus, Type 2 ; Humans ; Liraglutide
SCR Disease Name:
Mason-Type Diabetes
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 1017778

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz